BACKGROUND: Exercise stimulates the vascular response in pathological conditions, including ischemia; however, the molecular mechanisms by which exercise improves the impaired hypoxia-induced factor (HIF)-1 alpha-mediated response to hypoxia associated with aging are poorly understood. Here, we report that swimming training (ST) modulates the vascular response to ischemia in aged (24-month-old) mice. METHODS AND RESULTS: Aged wild-type mice (MMP-2(+/+)) that maintained ST (swimming 1 h/d) from day 1 after surgery were randomly assigned to 4 groups that were treated with either vehicle, LY294002, or deferoxamine for 14 days. Mice that were maintained in a sedentary condition served as controls. ST increased blood flow, capillary density, and levels of p-Akt, HIF-1 alpha, vascular endothelial growth factor, Fit-1, and matrix metalloproteinase-2 (MMP-2) in MMP-2(+/+) mice. ST also increased the numbers of circulating endothelial progenitor cells and their function associated with activation of HIF-1 alpha. All of these effects were diminished by LY294002, an inhibitor of phosphatidylinositol 3-kinase; enhanced by deferoxamine, an HIF-1 alpha stabilizer; and impaired by knockout of MMP-2. Finally, bone marrow transplantation confirmed that ST enhanced endothelial progenitor cell homing to ischemic sites in aged mice. CONCLUSIONS: ST can improve neovascularization in response to hypoxia via a phosphatidylinositol 3-kinase-dependent mechanism that is mediated by the HIF-1 alpha/vascular endothelial growth factor/MMP-2 pathway in advanced age.
BACKGROUND: Exercise stimulates the vascular response in pathological conditions, including ischemia; however, the molecular mechanisms by which exercise improves the impaired hypoxia-induced factor (HIF)-1 alpha-mediated response to hypoxia associated with aging are poorly understood. Here, we report that swimming training (ST) modulates the vascular response to ischemia in aged (24-month-old) mice. METHODS AND RESULTS: Aged wild-type mice (MMP-2(+/+)) that maintained ST (swimming 1 h/d) from day 1 after surgery were randomly assigned to 4 groups that were treated with either vehicle, LY294002, or deferoxamine for 14 days. Mice that were maintained in a sedentary condition served as controls. ST increased blood flow, capillary density, and levels of p-Akt, HIF-1 alpha, vascular endothelial growth factor, Fit-1, and matrix metalloproteinase-2 (MMP-2) in MMP-2(+/+) mice. ST also increased the numbers of circulating endothelial progenitor cells and their function associated with activation of HIF-1 alpha. All of these effects were diminished by LY294002, an inhibitor of phosphatidylinositol 3-kinase; enhanced by deferoxamine, an HIF-1 alpha stabilizer; and impaired by knockout of MMP-2. Finally, bone marrow transplantation confirmed that ST enhanced endothelial progenitor cell homing to ischemic sites in aged mice. CONCLUSIONS:ST can improve neovascularization in response to hypoxia via a phosphatidylinositol 3-kinase-dependent mechanism that is mediated by the HIF-1 alpha/vascular endothelial growth factor/MMP-2 pathway in advanced age.
Authors: Jay M Edelberg; Seung H Lee; Manmeen Kaur; Lilong Tang; Nikki M Feirt; Samuel McCabe; Orville Bramwell; S Chiu Wong; Mun K Hong Journal: Circulation Date: 2002-02-05 Impact factor: 29.690
Authors: Lixin Liu; Guy P Marti; Xiaofei Wei; Xianjie Zhang; Huafeng Zhang; Ye V Liu; Manuel Nastai; Gregg L Semenza; John W Harmon Journal: J Cell Physiol Date: 2008-11 Impact factor: 6.384
Authors: Ying Ann Chiao; Qiuxia Dai; Jianhua Zhang; Jing Lin; Elizabeth F Lopez; Seema S Ahuja; Youn-Min Chou; Merry L Lindsey; Yu-Fang Jin Journal: Circ Cardiovasc Genet Date: 2011-06-17
Authors: Christopher R deFilippi; James A de Lemos; Andrew T Tkaczuk; Robert H Christenson; Mercedes R Carnethon; David S Siscovick; John S Gottdiener; Stephen L Seliger Journal: J Am Coll Cardiol Date: 2012-11-14 Impact factor: 24.094